DRUG
BRIGHT MINDS BIOSCIENCES INC.
Next earnings Aug 12, 2026
$65.79
▲ +3.38%$65.79▲ +142.86%
over 1Y
L $23.27EODHDH $95.99
Today+3.4%
1W+3.6%
1M-24.4%
3M-6.1%
YTD-21.2%
1Y+142.9%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Mixed signals in the latest filings.
BRIGHT MINDS BIOSCIENCES INC. shows limited reported revenue.
Financials · annual, by fiscal year
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$298M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt—
Net cash—
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+1.3%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗6-KPeriod ending 2026-03-312026-06-03open ↗6-KPeriod ending 2026-01-202026-06-02open ↗6-KPeriod ending 2026-05-262026-05-28open ↗6-KPeriod ending 2026-03-312026-05-20open ↗SCHEDULE 13GFiling2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-15open ↗SCHEDULE 13G/AFiling2026-05-12open ↗SCHEDULE 13G/AFiling2026-04-30open ↗4Period ending 2026-04-282026-04-30open ↗SCHEDULE 13G/AFiling2026-02-17open ↗SCHEDULE 13G/AFiling2026-02-17open ↗
Frequently asked
- Is BRIGHT MINDS BIOSCIENCES INC. (DRUG) a buy?
- DRUG currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
Sources: SEC EDGAR (CIK 0001827401, latest 6-K filed 2026-06-03) · EODHD · as of 6/28/2026, 12:48:11 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.